Yao Liu
Shenyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Circ_PUM1 promotes the development of endometrial cancer by targeting the miR-136/NOTCH3 pathway.
Journal: Journal of cellular and molecular medicine
Published: May 09, 2019
CircRhoC promotes tumorigenicity and progression in ovarian cancer by functioning as a miR-302e sponge to positively regulate VEGFA.
Journal: Journal of cellular and molecular medicine
Published: March 08, 2019
circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 26, 2018
circPUM1 Promotes Tumorigenesis and Progression of Ovarian Cancer by Sponging miR-615-5p and miR-6753-5p.
Journal: Molecular therapy. Nucleic acids
Published: November 07, 2018
PUM1 promotes ovarian cancer proliferation, migration and invasion.
Journal: Biochemical and biophysical research communications
Published: January 26, 2018
lncRNA DLEU1 contributes to tumorigenesis and development of endometrial carcinoma by targeting mTOR.
Journal: Molecular carcinogenesis
Published: October 20, 2017
LncRNA PCGEM1 Induces Ovarian Carcinoma Tumorigenesis and Progression Through RhoA Pathway.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: October 09, 2017
The role of long non-coding RNA PCA3 in epithelial ovarian carcinoma tumorigenesis and progression.
Journal: Gene
Published: June 04, 2017
Fascaplysin inhibit ovarian cancer cell proliferation and metastasis through inhibiting CDK4.
Journal: Gene
Published: June 03, 2017
DLEU1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR-490-3p and altering CDK1 expression.
Journal: Journal of cellular and molecular medicine
Published: December 04, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026